Advances in Brain Science: 2025 Breakthroughs and 2026 Outlook

Brain science has advanced by leaps and bounds in 2025, marking a year of remarkable innovation and transformative discoveries across multiple frontier areas. We have witnessed breakthroughs in several domains that have redefined the boundaries of our understanding and application of brain science.

In the field of brain-computer interfaces (BCIs), 2025 saw unprecedented progress in clinical translation and technological miniaturization. China successfully conducted invasive BCI clinical trials with an implantable device merely 26mm in diameter and less than 6mm in thickness—no larger than a coin—achieving an end-to-end signal delay of under 100 milliseconds, even lower than the 200-millisecond conduction speed of the human natural neural circuit. This breakthrough enabled paralyzed patients to control wheelchairs, robot dogs for food delivery, and even play chess and racing games through pure thinking, realizing seamless “think-and-do” synchronization. Globally, Neuralink made pivotal strides in industrialization preparation, with its second-generation surgical robot reducing single-electrode implantation time from 17 seconds to 1.5 seconds and achieving deep-brain implantation up to 50mm, tripling signal acquisition resolution. The advent of dural-penetrating implantation technology also minimized surgical trauma, shortening the procedure from 6 hours to under 20 minutes and slashing costs by 95%, paving the way for widespread clinical adoption.

Neurological disease treatment also ushered in a new era in 2025, particularly for Alzheimer’s disease (AD). The annual Clinical Trials on Alzheimer’s Disease (CTAD) conference unveiled six key advances, including the potential of subcutaneous injection of lecanemab to replace intravenous infusion—maintaining equivalent efficacy while significantly reducing treatment costs and hospital visits. Revolutionary drug delivery technologies like Brainshuttle™ enhanced the ability of therapeutics such as trorinemab to cross the blood-brain barrier, lowering dosages and side effects while achieving amyloid-beta reduction in over 90% of patients. Additionally, animal experiments demonstrated that the drug P7C3-A20 could reverse AD progression by restoring NAD+ energy balance, repairing damaged brain tissue and fully recovering memory function in late-stage mice—a paradigm shift from “delaying decline” to “restoring function”.

Basic research on brain function and development also achieved milestone outcomes. A global collaborative team released the most detailed cross-species mammalian brain cell development atlas, tracking over 1.2 million inhibitory neurons in mice and revealing that brain cell diversification continues postnatally under sensory stimulation, highlighting the critical role of acquired experience in neural circuit maturation. Meanwhile, the development of the “DeepInMiniscope”—a grape-sized, 10g imaging system—enabled high-resolution, non-invasive real-time observation of neuronal activity in freely moving mice, integrating over 100 micro-lenses and neural networks to reconstruct high-quality 3D brain images, opening new avenues for studying brain-behavior relationships.

Against this backdrop of extraordinary progress, it will come as no surprise to see even more advances in brain science in 2026. With Neuralink announcing large-scale mass production of BCI devices and China’s national policies strongly supporting industrial innovation, the BCI industry is poised to transition from clinical validation to commercialization. The exploration of multi-target combination therapies for AD and the advancement of early intervention trials will further deepen our fight against neurodegenerative diseases.

Brain Science Advances is a journal dedicated exclusively to documenting and disseminating the most significant advancements in brain science. This year, we will continue to curate and publish high-impact, peer-reviewed articles that showcase cutting-edge breakthroughs across BCI technology, neurological disease therapeutics, brain development mechanisms, and neural imaging innovations. We are committed to serving as a premier platform for global researchers to share insights, accelerate collaboration, and drive the next wave of progress in this dynamic field.